After successful shipments earlier this year, Delta has proven capabilities for transporting COVID-19 vaccines. With large warehouses and cooler facilities in Atlanta, Detroit, Los Angeles, New York-JFK and Seattle, and a network of 49 certified Pharma airports across the globe, Delta has capabilities in place to support vaccine shipments at home and around the world. In addition to robust domestic shipment capabilities to support rapid distribution within the US, Delta has a broad and nimble global distribution function in coordination with Air France KLM Martinair Cargo and Virgin Atlantic Cargo that enables end-to-end compliance and assurance for customers across its broad network. “Effective and rapid distribution of the vaccines as they reach final approvals is one of the most critical elements in containing the virus,” said Rob Walpole, Vice President, Delta Cargo. “That’s why we created a vaccine task force months ago charged with understanding requirements and working with healthcare and pharmaceutical experts, building scalable solutions to support the industry. After successfully shipping test vaccines throughout the summer and fall, we are confident in our capability and stand ready to help ensure approved vaccines are broadly distributed,” he added.
Read More »Delta Cargo approves DoKaSch cooler for vaccine transportation
Delta Cargo has approved the use of the DoKaSchOpticooler RAP container as part of its cold chain pharma service. The approval comes as the air cargo industry prepares for the widespread transportation and distribution of Covid-19 vaccines. Key features of the DoKaSchOpticooler RAP container include: temperature ranges of 2-8°C and 15-25°C, which enable it to be used for the transportation of Pharma 1 goods without dry ice; a large loading compartment that accommodates five standard Euro pallets or four CP-1 pallets; a battery that requires two to four hours of charging time, operational times of up to 120 hours; and a large control panel plus quadruple redundancy for all critical parts, which help to ensure “backups for each feature in case of failure”. Shawn Cole, Delta’s vice president of cargo, commented, “The introduction of the Opticooler provides our customers with more choice when looking for reliable container options to support the growing global demand for pharma and vaccine shipments.” “Alongside our joint venture partners, Air France-KLM Cargo, we can now offer our customers a seamless experience across the trans-Atlantic, helping to keep supply chains moving and ensuring the safe delivery of temperature sensitive shipments during the current pandemic.” Andreas Seitz, managing director at DoKaSch Temperature Solutions, added: “This agreement with Delta provides more transport options for shippers of sensitive pharmaceutical goods, which is especially important for the upcoming transport of vaccines against Covid-19. Many of these will require a temperature range between 2°C and 8°C during transport, which is exactly what our Opticooler is made for. Delta further expands our extensive global network which allows us to offer our temperature-controlled packaging solutions at even more locations.”
Read More »